Brez internetne povezave — prikazana je shranjena različica strani.

Cingulate Inc

USUSD
← Na Filter Delnic

Cingulate Inc (US:CING) — Biotechnology: Pharmaceutical Preparations. Število borz, na katerih se trgujejo delnice družbe: 1. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
cingulate.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Sedež
KANSAS CITY, United States
Izvršni Direktor
Shane J. Schaffer Pharm.D.
Zaposleni
14
Delnice v Obtoku
14.54 mio. na dan 2026-08-12
Prosto Prenosljive Delnice
14.2 mio.
Tržna Kapitalizacija
69.22 mio. USD
Notranje Osebe
28.29%
Institucionalni Vlagatelji
12.59%
Panoga (SIC)
Pharmaceutical Preparations
P/E
izguba
FCF
−20.9 mio. USD
Dolg
1.15 mio. USD
neto denar
Dobiček in FCF — za 12 mesecev do 30.06.2026 (najnovejše poročilo podjetja).
NAV
1.69 USD · P/NAV 2.60
Datum Bilance Stanja30.06.2026
Sredstva33.1 mio. USD
− Obveznosti9.60 mio. USD
= NAV (lastniški delež delničarjev podjetja)23.5 mio. USD
= Opredmetena NAV23.5 mio. USD
Delnice13 894 882
NAV na Delnico1.69 USD
Otipljiv NAV na Delnico1.69 USD
Cena Delnice (CING)4.3900 USD
P/NAV2.60
Zgodovina NAV
Datum Bilance StanjaNAVNAV na Delnico
30.06.202623.5 mio. USD1.69 USD
31.03.202618.9 mio. USD1.58 USD
31.12.20252.51 mio. USD0.35 USD
30.09.20253.47 mio. USD0.58 USD
30.06.20255.51 mio. USD1.13 USD
31.03.20255.93 mio. USD1.55 USD
31.12.20247.46 mio. USD2.19 USD
30.09.202412.0 mio. USD3.95 USD
Opis

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksCINGUSD4.39 -3.94%navadne delnice

Cena v 3 Mesecih

US:CING · USD
dan rasti dan padcaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
Vanguard Capital Managem…3.93%570 8732026-06-30
VANGUARD INDEX FUNDS-Van…2.71%394 5552026-06-30
Chicago Partners Investm…1.3%188 4292026-06-30
Raymond James Financial,…1.15%166 8982026-06-30
VANGUARD INDEX FUNDS-Van…1.1%160 3962026-06-30
Kestra Advisory Services…1.04%151 5002026-06-30
Geode Capital Management…0.99%144 6362026-06-30
Renaissance Technologies…0.88%127 5002026-06-30
Vanguard Fiduciary Trust…0.54%79 1602026-06-30
Fidelity Concord Street…0.47%68 6752026-07-31
Blackrock Inc.0.37%53 1302026-06-30
Bcv Asset Management Inc…0.35%51 2002026-06-30
State Street Corporation0.33%47 8882026-06-30
iShares Trust-iShares Mi…0.19%27 8062026-08-31
Fidelity Concord Street…0.15%22 5332026-07-31
Fidelity Concord Street…0.13%18 5142026-07-31
SCHAFFER SHANE J. (Chief…≈0.1%14 2512026-03-09
CALLAHAN JENNIFER L. (Ch…≈0.1%13 9612026-03-09
Fidelity Concord Street…0.08%11 8882026-07-31
VANGUARD Inst. INDEX Fd.…0.07%10 2462026-06-30
BRAMS MATTHEW (Officer)≈0.06%8 1572026-03-09
VANGUARD VALLEY FORGE FU…0.04%5 6762026-06-30
SILVA RAUL R. (Officer)≈0.03%4 6452026-03-09
PATEL NILAY DAHYABHAI J.…≈0.02%3 3892026-03-09
EQ Advisors Trust-1290 V…0.01%1 8712026-06-30
MYERS LAURIE (Chief Oper…—02024-08-15
HARGROVES THOMAS JEFFREY…——2026-02-13
WERTH PETER J. (Director…——2026-02-06